1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,640 | 1,925 | 07:25 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Q-LINEA Aktie jetzt für 0€ handeln | |||||
| Fr | Q-Linea AB: Annika Blondeau Henriksson new interim CFO | 320 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) today announces that the company has hired Annika Blondeau Henriksson as CFO and IR. Annika takes office on June 15, 2026, when she succeeds Christer Samuelsson, who... ► Artikel lesen | |
| Mi | Q-linea AB: Bulletin From Annual General Meeting In Q-linea AB (publ) | 248 | GlobeNewswire (Europe) | The annual general meeting of Q-linea AB (publ) (the "Company"), reg. no. 556729-0217, was held on 27 May 2026 in Uppsala, at which the shareholders mainly passed the following resolutions. All resolutions... ► Artikel lesen | |
| 30.04. | Q-Linea AB: Interim report January - March 2026 | 281 | GlobeNewswire (Europe) | Growing recurring income and increased market activity within rapid AST
First quarter: 1 January-31 March 2026Income from sales of consumables amounted to SEK 1.4 (0.9) million, an increase of approx.... ► Artikel lesen | |
| 16.04. | Q-Linea AB: Q-linea announces FDA clearance of expanded ASTar blood testing menu | 466 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) today announces the company has received 510(k) clearance from the US FDA for its expanded ASTar® Gram-negative Blood Culture menu.
The expanded panel represents a significant... ► Artikel lesen | |
| 30.12.25 | Q-Linea AB: Q-linea signs first distribution agreement in South Asia | 439 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA today announces the signing of its first distribution agreement in South Asia, marking an important milestone in the company's global expansion strategy. The agreement... ► Artikel lesen | |
| 23.12.25 | Q-Linea AB: Q-linea announces first two US hospital systems' clinical implementation of ASTar | 231 | GlobeNewswire (Europe) | Q-linea AB (Publ) (OMX: QLINEA) announces the clinical implementation of the first US ASTar instruments at UI (University of Iowa) Health Care and a large healthcare system in Texas. UI Health Care... ► Artikel lesen | |
| 20.11.25 | Q-Linea AB: Q-linea announces new organisation and changes in executive leadership team | 384 | GlobeNewswire (Europe) | Q-linea AB (publ) (Nasdaq Stockholm: QLINEA) today announces that it has reached agreement with all relevant unions regarding the company's new organisation. As part of these changes, Ylva Molin has... ► Artikel lesen | |
| 18.11.25 | Q-Linea AB: Q-linea announces FDA submission for expanded claims for ASTar BC G- panel | 700 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) today announces their FDA 510(k) submission for expanded organism and antimicrobial claims on their ASTar BC G- panel, improving the clinical utility of the panel for... ► Artikel lesen | |
| 11.11.25 | Q-Linea AB: Q-linea announces outcome of rights issue | 229 | GlobeNewswire (Europe) | Q-linea AB (publ) ("Q-linea" or the "Company") (Nasdaq Stockholm: QLINEA) announces the outcome of the Company's rights issue of approximately SEK 322 (the "Rights Issue"), for which the subscription... ► Artikel lesen | |
| 24.10.25 | Listing of subscription rights and paid subscription shares of Q-Linea AB | 361 | GlobeNewswire | With effect from October 27, 2025, the subscription rights of Q-Linea AB will be traded on the list for Equity rights. Trading will continue up until and including November 05, 2025.
Instrument:
Subscription... ► Artikel lesen | |
| 22.10.25 | Q-Linea AB: Q-linea announces cost efficiency program to accelerate sales and marketing activities | 251 | GlobeNewswire (Europe) | Driven by Q-linea's strong commercial progression with a growing customer base, Q-linea today announced a cost efficiency program to optimise the organisation and cost structure to meet the increasing... ► Artikel lesen | |
| 21.10.25 | Q-Linea AB: Bulletin from Extraordinary General Meeting in Q-Linea AB (publ) | 237 | GlobeNewswire (Europe) | The extraordinary general meeting of Q-linea AB (publ) (the "Company"), org.nr. 556729-0217, was held on October 21, 2025 in Uppsala, Sweden, at which the shareholders primarily resolved as follows.... ► Artikel lesen | |
| 21.10.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 21.10.2025 | 329 | Xetra Newsboard | Das Instrument 3F80 SE0025420714 Q-LINEA AB EQUITY wird cum Kapitalmassnahme gehandelt am 21.10.2025 und ex Kapitalmassnahme am 22.10.2025 The instrument 3F80 SE0025420714 Q-LINEA AB EQUITY is traded... ► Artikel lesen | |
| 20.10.25 | Q-Linea AB: Interim report 1 January - 30 September 2025 | 251 | GlobeNewswire (Europe) | Strong pipeline growth while the installed base of ASTar increases demand for consumables
The quarter July - September 2025Net sales amounted to SEK 3.5 (0.6) million.Operating result (EBIT) of SEK... ► Artikel lesen | |
| 19.10.25 | Q-Linea AB: Stuart Gander appointed CEO and Anders Ljunggren appointed deputy CEO of Q-linea AB | 244 | GlobeNewswire (Europe) | The board of directors of Q-linea AB (publ) has today appointed Stuart Gander as CEO of the company. Former CEO Anders Ljunggren continues as deputy CEO of the company.
Since March 1, 2024, Stuart Gander... ► Artikel lesen | |
| 03.10.25 | Q-Linea AB: US Trauma Center signs commercial contract | 367 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) announces adoption of the first Accelerate Pheno conversion to the ASTar system by a prominent US level 1 University Hospital Trauma Center.
The University hospital selected... ► Artikel lesen | |
| 18.09.25 | Q-Linea AB: Q-linea | Letter from the CEO | 297 | GlobeNewswire (Europe) | Q-linea AB (publ) (OMX: QLINEA) today shared a Company update.
Key messagesReiterating target of 30 - 40 ASTar units contracted by end of year 2025 with outlook for 100 - 120 by end of 2026 and exceeding... ► Artikel lesen | |
| 18.09.25 | Q-Linea AB: Q-linea resolves to carry out a rights issue of approximately SEK 322 million and announces terms | 374 | GlobeNewswire (Europe) | Q-linea AB (publ) ("Q-linea" or the "Company") (Nasdaq Stockholm: QLINEA), announces that the board of directors today has resolved to carry out a share issue of approximately SEK 322 million with preferential... ► Artikel lesen | |
| 05.09.25 | Q-Linea AB: Q-linea to initiate new clinical evaluations of ASTar in the GCC region | 498 | GlobeNewswire (Europe) | Q-linea AB (Publ) (OMX: QLINEA) announces 2 new clinical evaluations of ASTar in Saudi Arabia and Kuwait.
Q-linea, through the distributor partner AMICO Group, is moving into clinical evaluation of... ► Artikel lesen | |
| 14.07.25 | XFRA NEW INSTRUMENTS AVAILABLE ON 14.07.2025 | 750 | Xetra Newsboard | The following instruments on XETRA do have their first trading 14.07.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 14.07.2025
Aktien
1 PLK2ITR00010 Fabrity S.A.
2 SE0013512506... ► Artikel lesen |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 35,450 | -2,26 % | dpa-AFX-Überblick: UNTERNEHMEN vom 26.05.2026 - 15.15 Uhr | Schwerwiegende Bedenken: BP trennt sich von Verwaltungsratschef - Kursrutsch LONDON - Der britische Ölkonzern BP setzt seinen Verwaltungsratschef Albert Manifold wegen Vorwürfen vor die Tür. Als... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 36,400 | -2,12 % | FMC startet Aktienrückkauf über eine Milliarde Euro | Die Fresenius Medical Care AG hat ein Aktienrückkaufprogramm mit einem Gesamtvolumen von rund einer Milliarde Euro beschlossen, das innerhalb von zwölf Monaten in Tranchen umgesetzt werden soll. Grundlage... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 26,020 | +0,54 % | EQS-DD: Carl Zeiss Meditec AG: Peter Kameritsch, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
28.05.2026 / 14:57... ► Artikel lesen | |
| DRAEGERWERK | 89,70 | -2,29 % | JEFFERIES stuft Draegerwerk auf 'Hold' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Drägerwerk von 73 auf 90 Euro angehoben, aber die Einstufung auf "Hold" belassen. Die Margenentwicklung des Spezialisten... ► Artikel lesen | |
| INTUITIVE SURGICAL | 354,00 | -0,13 % | Intuitive Surgical, Inc.: Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton | SUNNYVALE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the... ► Artikel lesen | |
| MEDTRONIC | 63,90 | +0,47 % | Is Medtronic Stock Underperforming the Nasdaq? | ||
| THERMO FISHER | 426,30 | +0,38 % | Laufende Fusionskontrollverfahren: Astorg Group S.à.r.l., Luxemburg; mittelbarer Erwerb alleiniger Kontrolle über den Mikrobiologie-Geschäftsbereich von Thermo Fisher Scientific Inc., Waltham/MA/USA (u.a. Oxoid Deutschland GmbH) | Datum der Anmeldung:22.05.2026Aktenzeichen:B3-68/26Unternehmen:Astorg Group S.à.r.l., Luxemburg; mittelbarer Erwerb alleiniger Kontrolle über den Mikrobiologie-Geschäftsbereich von Thermo Fisher Scientific... ► Artikel lesen | |
| TELADOC HEALTH | 6,826 | +0,44 % | TDOC Stock Pops as Teladoc Teams Up With Walmart | ||
| ROKU | 110,62 | -0,32 % | Aurzen Unveils the EAZZE D1R: The UK's First Roku TV Smart Projector for Effortless Big-Screen Streaming | LONDON, June 1, 2026 /PRNewswire/ -- Aurzen today announced the UK launch of the Aurzen Roku TV EAZZE D1R, the country's first smart projector powered by the Roku TV OS.Powered by the intuitive... ► Artikel lesen | |
| HIMS & HERS HEALTH | 23,920 | +0,25 % | Hims & Hers Expands Integrated Health Access via Platform Expansion | ||
| SERNOVA BIOTHERAPEUTICS | 0,100 | +5,27 % | Sernova Biotherapeutics: Sernova Biotherapeutics Announces Closing of Recently Approved Financings | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - April 23, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSHO) (XETRA: PSHO) ("Sernova" or the "Company"), a leading... ► Artikel lesen | |
| ALCON | 56,62 | +0,18 % | CH-Verlauf: Hoffnung auf Kriegsende sorgt für Schub - Alcon brechen ein | Zürich - Der Schweizer Aktienmarkt steht am Mittwoch deutlich im Plus. Die Anfangsgewinne hat der SMI dabei stetig ausgebaut, ehe kurz vor Mittag nochmals ein deutlicher Sprung nach oben gelang. Dieser... ► Artikel lesen | |
| DEXCOM | 65,40 | +1,55 % | DEXCOM INC - 8-K, Current Report | ||
| SIEMENS HEALTHINEERS | 34,260 | -1,89 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. a) der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung (EU)... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 13,290 | -0,08 % | Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation | ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced leadership updates that further strengthen the organization as the company continues to scale... ► Artikel lesen |
Q-LINEA AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 1,670 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu Q-LINEA AB finden Sie auf Wallstreet Online.